EHA 2019 | CLL & CAR-T: the intricacies and potential

David Maloney

David Maloney, MD, PhD, Fred Hutchinson Cancer Research Center, Seattle, WA, discusses the use of CAR T-cell therapy in chronic lymphocytic leukemia (CLL) and the potential of the treatment at the 24th Congress of the European Hematology Association (EHA) 2019, held in Amsterdam, Netherlands.

Share this video  
Similar topics